Results 221 to 230 of about 3,757,153 (283)

Early gut microbial and metabolic dysregulation with subclinical cardiac alterations in a nonhuman primate model of Rett syndrome. [PDF]

Imeta
Zhang T, Wang X, Li P, Zhang J, Sun W, Zhang Z, Zhuo Y, Guo W, Chen Y.   +8 more
europepmc   +1 more source

Single-nucleus profiling reveals a core disease signature and cell type-specific vulnerabilities in early Rett syndrome. [PDF]

Sci Adv
Li Y, Anderson AG, Qi G, Wu SR, Revelli JP, Chen H, Liu Z, Zoghbi HY.   +7 more
europepmc   +1 more source

MeCP2 NID interaction with RNA: implications for Rett syndrome-relevant protein regulation. [PDF]

Hum Mol Genet
Good KV, Strickfaden H, Muhammad T, Vincent JB, Hendzel M, Nelson CJ, Ausió J.   +6 more
europepmc   +1 more source

Anticodon-engineered tRNAs restore full-length MeCP2 expression and function in Rett syndrome nonsense mutations. [PDF]

Front Neurol
Fara E, Pezzini S, Arpaia G, Frasca A, Porter JJ, Lueck JD, Landsberger N.   +6 more
europepmc   +1 more source

Profiling metabotropic glutamate receptor 7 expression in Rett syndrome: consequences for pharmacotherapy. [PDF]

Neuroscience
Vermudez SAD, Freitas GA, Smith M, Gogliotti RG, Niswender CM.   +4 more
europepmc   +1 more source

MeCP2 Dosage Control in Rett Syndrome: Non-Coding RNA-Based and Epigenetic Strategies for Safer Gene Therapy. [PDF]

Noncoding RNA
Kabdesh IM, Rizvanov AA, Mukhamedshina YO.   +2 more
europepmc   +1 more source

Modulating alternative splicing of <i>MECP2</i> is a potential therapeutic strategy for Rett syndrome. [PDF]

Sci Transl Med
Tirumala HP, Wang L, Li Y, Bajikar SS, Anderson AG, Wang W, Trostle AJ, Zahabiyon M, Bajic A, Kim JJ, Chen H, Liu Z, Zoghbi HY.   +12 more
europepmc   +1 more source